Ratings by JPMorgan (Joyce Zhou)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | Hemab Therapeutics Holdings | COAG | New Coverage | Overweight (N/A) |
29.80 (35.73) |
19.9% | Details | |
| 9/17/2026 | Prelude Therapeutics | PRLD | New Coverage | Overweight (N/A) |
4.52 (3.72) |
-17.7% | Details |
